Complement deficiencies in patients over ten years old with meningococcal disease due to uncommon serogroups

C A Fijen1, E J Kuijper, A J Hannema

  • 1Department of Medical Microbiology, University of Amsterdam Academic Medical Centre, the Netherlands.

Lancet (London, England)
|September 9, 1989
PubMed

Insights

Half of patients with rare meningococcal disease serogroups had complement deficiencies. Terminal complement component deficiencies were linked to recurrent infections, highlighting the link between complement and meningococcal disease.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Genetics

Background:

  • Meningococcal disease is typically caused by specific serogroups.
  • Infections with less common serogroups (X, Y, Z, W135, 29E) after age 10 are unusual.
  • Complement deficiencies are known risk factors for meningococcal disease.

Purpose of the Study:

  • To investigate the association between complement deficiencies and meningococcal disease caused by uncommon serogroups.
  • To identify specific complement deficiencies prevalent in patients with these infections.

Main Methods:

  • Retrospective investigation of 46 patients diagnosed with meningococcal disease due to serogroups X, Y, Z, W135, or 29E after age 10.
  • Analysis of complement component levels and function in affected patients.

Main Results:

  • Complement deficiency was identified in 50% of the patients studied.
  • Properdin deficiency was found in 9 patients.
  • C3 deficiency syndromes in 5 patients, and homozygous deficiencies of terminal components (C5-C8) in 9 patients.
  • Recurrent meningococcal infections occurred in 5 of the 9 patients with terminal complement component deficiencies.

Conclusions:

  • Meningococcal disease caused by uncommon serogroups is frequently associated with underlying complement deficiency.
  • Terminal complement component deficiencies represent a significant risk for recurrent meningococcal infections.
  • Screening for complement deficiencies should be considered in patients with invasive disease due to unusual meningococcal serogroups.

Related Concept Videos

Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...